Text Size

Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Lazzaro, C.; van Steen, C.; Billeit, S.; Frauenknecht, H.; Kallen, C.; Pfennigsdorf, S.; Thelen, U.; Angelillo, L.


  • 2022
  • Clinical Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Affiliations

    Health Economist and Research Director, Studio di Economia Sanitaria, Milan, Italy; Santen GmbH, München, Germany; Private Practicing Ophthalmologist, Lübeck, Germany; Private Practicing Ophthalmologist, Treuchtlingen, Germany; Private Practicing Ophthalmologist, Krefeld, Germany; Private Practicing Ophthalmologist, Polch, Germany; Private Practicing Ophthalmologist, Münster, Germany; University Hospital Muenster, Department of Ophthalmology, Münster, Germany

Related Publications

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022